In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Panacos Pharmaceuticals Inc.

www.panacos.com

Latest From Panacos Pharmaceuticals Inc.

Bristol Advancing Two New Mechanisms In HIV, With Focus On Treatment-Experienced Patients

An attachment inhibitor entering Phase III may offer a new option for patients who have outlived the utility of other antiretrovirals. Bristol also is advancing a second-generation maturation inhibitor of HIV into Phase IIb studies, hoping to succeed where other candidates failed to address viral mutation.

BioPharmaceutical Clinical Trials

DFH partnering with US NCI on new HIV antiretrovirals

DFH Pharma has teamed with the US National Cancer Institute (NCI) to further the development of next-generation HIV maturation inhibitors, a new class of antiretroviral drugs.

Infectious Diseases Cancer

Alan Dunton joins EpiCept as non-executive chair

EpiCept Corporation, focused on the development and commercialisation of treatments for cancer and pain, has appointed Dr Alan Dunton to its board of directors as non-executive chair. Dr Dunton replaces Bob Savage, who will remain on the board as a director. Dr Dunton is the founder of Danerius, a consulting company that advises pharma and biotech companies on issues related to drug development. He is also a director at Targacept, Palatin Technologies and Oragenics. He previously served as president and CEO of Panacos Pharmaceuticals.

Cancer Neurology

Dr Alan Dunton joins Palatin Technologies' board

Palatin Technologies has appointed Dr Alan Dunton to its board of directors as an independent director and member of its audit and compensation committees. Dr Dunton is president and principal of Danerius, a consulting company he founded in 2006, and he previously served as president and CEO of Panacos Pharmaceuticals.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Vitex
  • VI Technologies Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Panacos Pharmaceuticals Inc.
  • Senior Management
  • Alan W Dunton, MD, Pres. & CEO
    Frederick Schmid, SVP, Bus. Dev.
    David E Martin, SVP, Drug Dev.
  • Contact Info
  • Panacos Pharmaceuticals Inc.
    Phone: (617) 926-1551
    134 Coolidge Ave.
    Watertown, MA 02472
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register